» Articles » PMID: 15694831

AC133/CD133/Prominin-1

Overview
Publisher Elsevier
Date 2005 Feb 8
PMID 15694831
Citations 155
Authors
Affiliations
Soon will be listed here.
Abstract

Prominin-1, originally found on neuroepithelial stem cells in mice, is a five transmembrane domain cell-surface glycoprotein that localizes to membrane protrusions. Its homologue human Prominin-1 was first isolated from hematopoietic stem cells by a monoclonal antibody recognizing a specific epitope designated as AC133 (CD133). Transcription of Prominin-1 is driven by five tissue-specific alternative promoters resulting in the formation of differentially spliced mRNA isoforms. Prominin-1 is expressed on different types of stem cells, but it is not known if it plays a significant role in key stem cell functional features. Although the biological function of Prominin-1 is not well understood, the AC133 epitope currently serves as a useful marker for the isolation of hematopoietic and endothelial progenitor cells.

Citing Articles

Unveiling the impact of CD133 on cell cycle regulation in radio- and chemo-resistance of cancer stem cells.

Wu L, Katsube T, Li X, Wang B, Xie Y Front Public Health. 2025; 13:1509675.

PMID: 39980929 PMC: 11839412. DOI: 10.3389/fpubh.2025.1509675.


Farnesoid X Receptor Attenuates the Tumorigenicity of Liver Cancer Stem Cells by Inhibiting STAT3 Phosphorylation.

Ye W, Zhao Y, Wang Y, Wang Y, Zhang H, Wang F Int J Mol Sci. 2025; 26(3).

PMID: 39940889 PMC: 11817294. DOI: 10.3390/ijms26031122.


Deciphering the impact of PROM1 alternative splicing on human photoreceptor development and maturation.

Moya-Molina M, Dorgau B, Flood E, Letteboer S, Lorentzen E, Coxhead J Cell Death Dis. 2024; 15(10):721.

PMID: 39353897 PMC: 11445533. DOI: 10.1038/s41419-024-07105-7.


The Impact of Glycosylation on the Functional Activity of CD133 and the Accuracy of Its Immunodetection.

Gisina A, Yarygin K, Lupatov A Biology (Basel). 2024; 13(6).

PMID: 38927329 PMC: 11200695. DOI: 10.3390/biology13060449.


Can CD133 Be Regarded as a Prognostic Biomarker in Oncology: Pros and Cons.

Gisina A, Kim Y, Yarygin K, Lupatov A Int J Mol Sci. 2023; 24(24).

PMID: 38139228 PMC: 10744290. DOI: 10.3390/ijms242417398.